These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22650028)

  • 1. [The role of oxidative stress in the pathogenesis of polycystic ovary syndrome].
    Liu J; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):187-90. PubMed ID: 22650028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.
    Kuşçu NK; Var A
    Acta Obstet Gynecol Scand; 2009; 88(5):612-7. PubMed ID: 19308750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating levels of oxidative stress and adipocytokines in obese subjects].
    Shen XP; Zou SB; Wu HJ; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):721-3. PubMed ID: 18616920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum visfatin is elevated in Chinese women with polycystic ovary syndrome, but might not be a reliable predictor of their glucose intolerance.
    Hong Y; Zhao XM; Huang LL; Li L; Chen XL; Yang DZ
    J Biol Regul Homeost Agents; 2012; 26(2):221-9. PubMed ID: 22824749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
    Gen R; Akbay E; Muslu N; Sezer K; Cayan F
    Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visfatin and oxidative stress influence endothelial progenitor cells in obese populations.
    Chen S; Sun L; Gao H; Ren L; Liu N; Song G
    Endocr Res; 2015; 40(2):83-7. PubMed ID: 25207957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
    Pepene CE
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
    Vagiri D; Barletta C; Cioli I; Scavo D
    Minerva Endocrinol; 1994 Mar; 19(1):5-12. PubMed ID: 8035770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of simvastatin on plasma SOD, MDA and 8-iso-PGF2α in patients with stable angina].
    Zhang F; Wu SZ; Zhang L; Hong L; Lai WY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2646-8. PubMed ID: 21177169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of oxidative stress to PCOS].
    Zhang D; Luo WY; Liao H; Wang CF; Sun Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):421-3. PubMed ID: 18575330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF; Ren FR; Guo SP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of oxidative stress in development of acute high altitude response during the process of strong physical work at high altitude].
    Yang SY; Feng EZ; Yan ZQ; He W; Tian ZX; Yin H; Ma LF; Zhou QQ; Shi ZF
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Nov; 27(4):457-60. PubMed ID: 22295525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.